PHARMACYCLICS INC's ticker is PCYC and the CUSIP is 716933106. A total of 252 filers reported holding PHARMACYCLICS INC in Q2 2014. The put-call ratio across all filers is 1.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,098,000 | +109.5% | 4,290 | 0.0% | 0.01% | +100.0% |
| Q4 2014 | $524,000 | +6.9% | 4,290 | +2.7% | 0.00% | 0.0% |
| Q3 2014 | $490,000 | +30.0% | 4,176 | -0.7% | 0.00% | +33.3% |
| Q2 2014 | $377,000 | -6.5% | 4,207 | +4.6% | 0.00% | 0.0% |
| Q1 2014 | $403,000 | -5.2% | 4,021 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $425,000 | -23.7% | 4,021 | 0.0% | 0.00% | -25.0% |
| Q3 2013 | $557,000 | +71.9% | 4,021 | -1.3% | 0.00% | +33.3% |
| Q2 2013 | $324,000 | – | 4,075 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 9,010,211 | $1,245,752,000 | 17.70% |
| DAFNA Capital Management LLC | 102,128 | $14,120,000 | 15.42% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 183,390 | $25,355,000 | 4.11% |
| QVT Financial LP | 344,321 | $47,606,000 | 3.24% |
| BB BIOTECH AG | 399,030 | $55,170,000 | 3.00% |
| LMR Master Fund Ltd | 87,269 | $12,079,000 | 2.31% |
| Ithaka Group | 65,420 | $9,045,000 | 2.10% |
| Geduld E E | 22,000 | $3,042,000 | 1.86% |
| Benchmark Capital Advisors | 17,250 | $2,385,000 | 1.71% |
| HealthCor Management, L.P. | 200,000 | $27,652,000 | 1.48% |